UnitedHealth Group Incorporated (UNH) — Analyst outlook / Analyst consensus target is. Based on 52 analyst ratings, the consensus is bullish — 41 Buy, 7 Hold, 4 Sell.
The consensus price target is $385.38 (low: $327.00, high: $444.00), representing an upside of 22.7% from the current price $314.19.
Analysts estimate Earnings Per Share (EPS) of $27.61 and revenue of $400.99B for the next fiscal year.
Earnings Per Share (EPS) track record: 2024: actual $15.51 vs est $27.61 (missed -43.8%). 2025: actual $13.23 vs est $16.32 (missed -18.9%). Analyst accuracy: 49%.
UNH Stock — 12-Month Price Forecast
$385.38
▲ +22.66% Upside
Average Price Target
Based on 52 Wall Street analysts offering 12-month price targets for UnitedHealth Group Incorporated, the average price target is $385.38, with a high forecast of $444.00, and a low forecast of $327.00.
The average price target represents a +22.66% change from the last price of $314.19.
Highest Price Target
$444.00
Average Price Target
$385.38
Lowest Price Target
$327.00
UNH Analyst Ratings
Buy
Based on 52 analysts giving stock ratings to UnitedHealth Group Incorporated in the past 3 months
EPS Estimates — UNH
49%
Analyst Accuracy
Inaccurate
2 years compared
Actual vs Estimate
2024
Actual $15.51
vs Est $27.61
▼ 78.0% off
2025
Actual $13.23
vs Est $16.32
▼ 23.4% off
Profitability Outlook
Strong profitability with high earnings per share. EPS trend is declining. Analysts forecast meaningful EPS growth ahead.
Revenue Estimates — UNH
100%
Analyst Accuracy
Accurate
2 years compared
Actual vs Estimate
2024
Actual $400.278B
vs Est $400.991B
▼ 0.2% off
2025
Actual $447.567B
vs Est $447.858B
▼ 0.1% off
Revenue Trend
Moderate revenue growth trend. Analysts forecast revenue contraction ahead.
